CLINICAL_TRIALS ClinicalTrials.gov record update

A Single-arm，Open Lable Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy（Irinotecan Plus Platinum）and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer（SCLC）

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04453930
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:39.849723+00:00
Published At: 2020-07-01T00:00:00+00:00
Record Updated At: 2020-07-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Small Cell Lung Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-07-01"
protocolSection.identificationModule.nctId: "NCT04453930"
protocolSection.identificationModule.officialTitle: "A Single-arm\uff0cOpen Lable Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy\uff08Irinotecan Plus Platinum\uff09and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer\uff08SCLC\uff09"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.